Showing results (151-160 of 219) with videos related to

Sort By:
Pageof 22
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approachPieter D de Veij Mestdagh, Iris Walraven, Wouter V Vogel, et al.
EJNMMI Research|July 27, 2022
Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective studyMaarten L Donswijk, Maurits Wondergem, Linda de Wit-van der Veen, et al.
The British Journal of Radiology|August 13, 2021
A decade of multi-modality PET and MR imaging in abdominal oncologyLisa A Min, Francesca Castagnoli, Wouter V Vogel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2010
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancerTjeerd S Aukema, Marieke E Straver, Marie-Jeanne T F D Vrancken Peeters, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 8, 2009
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniquesT S Aukema, E J Th Rutgers, W V Vogel, et al.
Clinical and Translational Radiation Oncology|May 6, 2020
[18F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trialsSebastian Sanduleanu, Olga Hamming-Vrieze, Frederik W R Wesseling, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2010
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patientsMarieke E Straver, Tjeerd S Aukema, Renato A Valdes Olmos, et al.
EJNMMI Research|April 28, 2016
Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with (124)IJakob W Kist, Manfred van der Vlies, Otto S Hoekstra, et al.
Annals of Surgical Oncology|March 5, 2013
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axillaBas B Koolen, Renato A Valdés Olmos, Jelle Wesseling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 27, 2015
124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)Jakob W Kist, Bart de Keizer, Manfred van der Vlies, et al.
Pageof 22